STEPHEN ROCAMBOLI - 03 Jul 2024 Form 4 Insider Report for TFF Pharmaceuticals, Inc. (TFFP)

Role
Director
Signature
/s/ Stephen C. Rocamboli, by Kirk Allen Coleman, as Attorney-in-Fact
Issuer symbol
TFFP
Transactions as of
03 Jul 2024
Net transactions value
$0
Form type
4
Filing time
08 Jul 2024, 17:41:33 UTC
Previous filing
24 May 2024
Next filing
02 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TFFP Common Stock Award $0 +3,165 +8.8% $0.000000 39,165 03 Jul 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TFFP Stock Options (Right to Buy) Award $0 +3,165 $0.000000 3,165 03 Jul 2024 Common stock 3,165 $1.82 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock underlying restricted stock units ("RSUs"). Each RSU entitles its holder to receive one share of common stock of the issuer. The RSUs vest and settle in full on June 19, 2025.
F2 Options vest in full on June 19, 2025.